Pardeep Kumar Sood - 03 Apr 2023 Form 3 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Reporting relationship: 10%+ Owner
Issuer ticker: BTAI
Reported as of: 03 Apr 2023
Net transaction value: $0
SEC form: 3
Accepted by SEC: 13 Apr 2023, 19:24:09 UTC
Source filing: View source filing
Reporting owner signature: /s/Pardeep Sood

Key filing fact

Pardeep Kumar Sood filed Form 3 for BioXcel Therapeutics, Inc. (BTAI) on 13 Apr 2023.

Key facts

This page summarizes Pardeep Kumar Sood's Form 3 filing for BioXcel Therapeutics, Inc. (BTAI).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 13 Apr 2023, 19:24.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BTAI holding

Common Stock, par value $0.001 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,546,750
Date: 03 Apr 2023
Ownership: By BioXcel LLC

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

The Reporting Person may be deemed to share investment control over shares of Common Stock of the Issuer held by BioXcel LLC and held indirectly by BioXcel Holdings, Inc. The reporting person disclaims beneficial ownership of the reported securities except to the extent, if any, of the reporting person's pecuniary interest therein, and this filing shall not be deemed an admission that the Reporting Person is, for purposes of Section 16 of the Securities Exchange Act or otherwise, the beneficial owner of any such shares of Common Stock.